• NeuroBo Pharmaceuticals complete Gemphire merger pharmaceutical-technology
    January 14, 2020
    NeuroBo Pharmaceuticals has completed its previously announced combination with Gemphire Therapeutics.The combined unit will operate as NeuroBo Pharmaceuticals with NeuroBo shareholders holding a 96.24% stake in the firm.
PharmaSources Customer Service